One study reported that miR-129 acts as a tumor suppressor, and its overexpression leads to decreased cell proliferation and viability of melanoma cells resistant to vemurafenib, possibly by modulating SOX4 expression [37]. The gene discussed is SOX4; the disease is neoplasm.